Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...

Richard Staines heard about this new strategy at the Veeva 2019 Commercial and Medical Summit, Europe. GSK’s approach to marketing content has had a major rethink in the last two years ...

GSK Plc is a healthcare company ... It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

In a statement, GSK chief commercial officer Luke Miels said that the drug "complements [the company's] growing portfolio in gastrointestinal cancers," which also includes anti-PD-1 antibody ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...

GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded as high ...

GSK reports under three segments: Specialty Medicines, Vaccines and General Medicines. Specialty Medicines, Vaccines and General Medicines are clubbed as commercial operations. Sales in the ...